Risk factors
Camp4 Therapeutics (CAMP) risk factors
Item 1A of every Camp4 Therapeutics Corp. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors81 risks6 new15 dropped18 reworded
Camp4 added specific disclosures on regulatory safety uncertainties for novel regulatory RNA-targeting ASOs, supply chain risks from Chinese biotech scrutiny under the BIOSECURE Act, and potential competition from established firms like Alnylam and Ionis.
Filed Mar 05, 2026 - FY2024 10-K risk factors90 risks
Clinical-stage biopharmaceutical company with significant accumulated losses, no approved products, and going concern doubt.
Filed Mar 27, 2025